bullish
Indegene Pre-IPO - Growing Client Base and Cross/Up-Selling Led to Growth
413 Views19 Apr 2023 10:51
Indegene Limited (1864095D IN) is looking to raise about US$400m in its upcoming India IPO. Indegene is a “digital-first” commercialisation firm with a focus on the global life sciences industry.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 10-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Indegene IPO - Marquee Clients, Strong Track Record, Decent Valuation03 May 2024
- Indegene Pre-IPO - RHP Updates - Client Base Continued to Grow, and Margins Have Begun Stabilizing02 May 2024
- Indegene Limited Pre-IPO: Subscribe on Profitable Niche Business Model and Attractive Valuation29 Apr 2024
- Indegene Pre-IPO - Growing Client Base and Cross/Up-Selling Led to Growth19 Apr 2023
- Indegene Pre-IPO Tearsheet22 Dec 2022
x